Filing Details

Accession Number:
0001077183-19-000212
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-18 12:30:48
Reporting Period:
2019-11-15
Accepted Time:
2019-11-18 12:30:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640500 Jennifer Balliet 12701 Commonwealth Drive Suite 9
Fort Myers FL 33913
Vp And Chief Culture Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-15 6,667 $7.52 29,529 No 4 M Direct
Common Stock Acquisiton 2019-11-15 166 $8.03 29,695 No 4 M Direct
Common Stock Disposition 2019-11-15 6,833 $23.45 22,862 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-11-15 6,667 $0.00 6,667 $7.52
Common Stock Stock Option (Right to Buy) Disposition 2019-11-15 166 $0.00 166 $8.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2018-04-28 2022-04-28 No 4 M Direct
48,334 2019-02-26 2023-02-26 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $19.60 2020-03-01 2024-03-01 17,496 17,496 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-03-01 17,496 17,496 Direct
Footnotes
  1. On April 28, 2017, Jennifer Balliet was granted 60,000 stock options which vest ratably over the first three anniversary dates of the grant date.
  2. On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vest ratably over the first three anniversary dates of the grant date.
  3. On March 1, 2019, Jennifer Balliet was granted 17,496 stock options which vest ratably over the first four anniversary dates of the grant date.